G. Ngian

Anti-Ro52/TRIM21 is independently associated with pulmonary arterial hypertension and mortality in a cohort of systemic sclerosis patients

M. Nikpour, J. Walker, J. Sahhar, 2021, Scandinavian journal of rheumatology.

Risk factors for development of pulmonary arterial hypertension in Australian systemic sclerosis patients: results from a large multicenter cohort study

S. Proudman, M. Nikpour, M. Rischmueller, 2016, BMC Pulmonary Medicine.

Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme

C. Hill, P. Nash, S. Proudman, 2017, Arthritis Research & Therapy.

Survival and quality of life in incident systemic sclerosis-related pulmonary arterial hypertension

C. Hill, D. Celermajer, P. Nash, 2017, Arthritis Research & Therapy.

Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality

M. Hudson, M. Baron, Mianbo Wang, 2018, Rheumatology.

Smooth muscle myopathy as an underrecognized manifestation of active systemic lupus erythematosus

P. Naidoo, A. Hoi, E. Morand, 2011, Internal medicine journal.

The impact of gastroesophageal reflux disease and its treatment on interstitial lung disease outcomes

N. Ferdowsi, L. Ross, W. Stevens, 2024, Arthritis research & therapy.